Basal and stimulation day 5 anti-Müllerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist–gonadotropin treatment

By Peñarrubia Joana  

Human Reproduction, Vol. 20, Iss. 4, 2005-04 ,pp. : 915-922

Oxford University Press

Access to resources Recommend Favorite

Controlled ovarian hyperstimulation using multi-dose gonadotropin-releasing hormone (GnRH) antagonist results in less systemic inflammation than the GnRH-agonist long protocol

By Orvieto Raoul   Volodarsky Michael   Hod Eduard   Homburg Roy   Rabinson Jacob   Zohav Efraim   Anteby Eyal   Meltcer Simion  

Gynecological Endocrinology, Vol. 23, Iss. 8, 2007-08 ,pp. : 494-496

Informa Healthcare

Access to resources Recommend Favorite

Dynamics of serum anti-Müllerian hormone levels during the luteal phase of controlled ovarian hyperstimulation

By Fanchin Renato  

Human Reproduction, Vol. 20, Iss. 3, 2005-03 ,pp. : 747-751

Oxford University Press

Access to resources Recommend Favorite

Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro

By Carlsson I.B.   Scott J.E.   Visser J.A.   Ritvos O.   Themmen A.P.N.   Hovatta O.  

Human Reproduction, Vol. 21, Iss. 9, 2006-09 ,pp. : 2223-2227

Oxford University Press

Access to resources Recommend Favorite

Anti-Müllerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovaries

By Kallio S.   Aittomäki K.   Piltonen T.   Veijola R.   Liakka A.   Vaskivuo T.E.   Dunkel L.   Tapanainen J.S.  

Human Reproduction, Vol. 27, Iss. 3, 2012-03 ,pp. : 854-860

Oxford University Press

Access to resources Recommend Favorite